Visit Health Bags Over INR 250 Cr To Boost Its Healthcare Play

SUMMARY

Visit Health has secured more than INR 250 Cr (about $29.8 Mn) in a mix of capital infusion from various investors and secondary purchase of stake in the company held by PB Fintech’s arm Docprime Technologies

The healthtech company is planning to deploy its funds to expand its business operations, including partnership with TatvaCare

The collaboration with TatvaCare will leverage capabilities of both companies and maximise their reach in the healthcare sector

Online healthcare service provider Visit Health has secured more than INR 250 Cr (about $29.8 Mn) in a mix of capital infusion from various investors and secondary purchase of stake in the company held by PB Fintech’s arm Docprime Technologies.

The secondary transaction also saw participation from Visit Health’s founders and ESOP buybacks as well. However, the company did not disclose the name of the investors participating in the current round.

The healthtech company is planning to deploy its funds to expand its business operations, including partnership with technology service provider for healthcare professionals TatvaCare.

The collaboration with TatvaCare will leverage capabilities of both companies and maximise their reach in the healthcare sector, the company said in a statement.

Founded in 2016 by Singh, Anurag Prasad, Chetan Anand and Shashvat Tripathi, Visit Health offers online consultations with physicians and other medical specialists. Apart from that, the company also engages with its users to provide diet and wellness coaching on its platform.

“This investment is a testament to the value and impact of our platform. With the strengthened partnership with TatvaCare, we are poised to expand our cashless network, services and enhance our commitment to delivering accessible, high-quality healthcare to everyone,” cofounder and managing director Vaibhav Singh said.

Visit Health also said that with the new investment and strengthened partnership with TatvaCare, it is set to provide accessible, cost-effective, and quality healthcare.

This comes weeks after Abhay HealthTech, which offers various home diagnostics and rapid testing kits, roped in Indian actor Vindu Dara Singh as an investor without disclosing the financial terms of the deal.